Tiumbio Co., Ltd.
Records under this name other than the patents Tiumbio Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 4 of 4 · Back to Tiumbio Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,643,946 | Tricyclic compound and use thereof Lapsed on the fee record Ended May 9, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 9, 2025 | From the USPTO record |
| US 9,644,197 | Fusion protein having factor VII activity Lapsed on the fee record Ended May 9, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 9, 2025 | From the USPTO record |
| US 8,410,146 | 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors Term ended Term ended Nov 8, 2024 · From the USPTO record | Term ended | Term ended Nov 8, 2024 | From the USPTO record |
| US 9,034,850 | Gonadotropin releasing hormone receptor antagonist, preparation method thereof and pharmaceutical composition comprising the same Lapsed on the fee record Ended May 19, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 19, 2023 | From the USPTO record |